elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35688425-9262A2CB-F5F5-4C6B-9C74-913EA5B916E6
Q35688425-9262A2CB-F5F5-4C6B-9C74-913EA5B916E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35688425-9262A2CB-F5F5-4C6B-9C74-913EA5B916E6
Prostate cancer immunotherapy.
P2860
Q35688425-9262A2CB-F5F5-4C6B-9C74-913EA5B916E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35688425-9262A2CB-F5F5-4C6B-9C74-913EA5B916E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5b33ba93c507cc6c8cc72c6f9ba72cdb305dd6ca
P2860
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion